Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome

Joint Authors

Bunker, Daniel
Kerr, Leslie Dubin

Source

Case Reports in Rheumatology

Issue

Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-4, 4 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2016-10-24

Country of Publication

Egypt

No. of Pages

4

Main Subjects

Diseases

Abstract EN

Importance.

Rituximab was not effective in ameliorating the hearing loss in a patient with atypical Cogan’s syndrome.

Observations.

We report the case of a patient who developed acute bilateral uveitis and sensorineural hearing loss.

A diagnosis of atypical Cogan’s syndrome was made.

The patient’s hearing loss did not improve despite high dose steroids and azathioprine.

Rituximab was administered given a recent report of its efficacy in a patient with refractory disease; however, our patient’s hearing loss did not improve.

Conclusion.

Hearing loss in Cogan’s syndrome is difficult to treat.

Though rituximab was ineffective in our case, earlier administration in the disease course could be effective for future patients.

American Psychological Association (APA)

Bunker, Daniel& Kerr, Leslie Dubin. 2016. Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome. Case Reports in Rheumatology،Vol. 2016, no. 2016, pp.1-4.
https://search.emarefa.net/detail/BIM-1102671

Modern Language Association (MLA)

Bunker, Daniel& Kerr, Leslie Dubin. Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome. Case Reports in Rheumatology No. 2016 (2016), pp.1-4.
https://search.emarefa.net/detail/BIM-1102671

American Medical Association (AMA)

Bunker, Daniel& Kerr, Leslie Dubin. Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome. Case Reports in Rheumatology. 2016. Vol. 2016, no. 2016, pp.1-4.
https://search.emarefa.net/detail/BIM-1102671

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1102671